Dehradun medtech start-up Sunfox raises $7 million for portable ECG device
AI-generated illustration
Advertisement
Dehradun's Sunfox Technologies, maker of the Spandan smartphone ECG, raised US$7 million in a Series A round reported on 7 October 2026.
What Happened
Sunfox Technologies, a medical technology start-up based in Dehradun, Uttarakhand, has raised US$7 million (about Rs 67 crore) in a Series A funding round, according to reports published on Wednesday, 7 October 2026. The round was led by investor Ashish Kacholia, Lashit Sanghvi, Alchemy Capital and 3one4 Capital. Sunfox makes Spandan, a portable electrocardiogram (ECG) device that works with a smartphone, allowing health workers and patients to record a heart tracing outside a hospital and share it with doctors. The company said the money will be used to grow in India, enter overseas markets and expand research and development.
Key Facts
- Amount: US$7 million, about Rs 67 crore, in a Series A round reported on 7 October 2026.
- Lead investors: Ashish Kacholia, Lashit Sanghvi, Alchemy Capital and 3one4 Capital.
- Product: Spandan, a portable ECG device that records heart tracings through a smartphone.
- Reach: about 60,000 Spandan devices across India, reaching more than 20,000 villages, the company says.
- Founded in 2016 in Dehradun by Rajat Jain, Arpit Jain, Sabit Rawat, Nitin Chandola and Saurabh Badola.
- Approvals: regulatory clearance in India, Ghana, Kenya, Tanzania and South Africa; it is seeking approval in the United States and the European Union.
- Previous funding: a Rs 15 crore round led by Venture Catalysts in 2024.
Why It Matters
Most Indian start-up funding still goes to companies in Bengaluru, Delhi-NCR and Mumbai. Sunfox is a reminder that a hardware and health company built in a smaller city like Dehradun can grow to national scale and attract well-known investors. Its founders started the company in 2016, which also shows how long it can take for a medical device business to reach this stage, given the need for testing, approvals and distribution.
The product addresses a real gap. An ECG is one of the most basic tests for spotting heart trouble, but in many villages there is no machine nearby and no cardiologist to read the result. A small device linked to a phone lets a frontline health worker take a reading and send it to a doctor elsewhere. The company says Spandan can also flag ECG patterns that may need urgent attention, which could help patients reach treatment faster. Those clinical claims come from the company and readers should treat them as such.
For young founders outside the metros, the deal offers some practical lessons. Sunfox built its base in rural and semi-urban India before looking abroad, collected approvals country by country, and is now using fresh capital to tackle tougher markets such as the US and Europe. Its investor mix, which includes individual investors as well as funds, also shows that early-stage money for medical devices can come from beyond traditional venture capital firms.
| Detail | Sunfox Technologies |
|---|---|
| Headquarters | Dehradun, Uttarakhand |
| Founded | 2016 |
| Latest round | US$7 million Series A |
| Devices in use | About 60,000 |
| Villages reached | More than 20,000 |
Impact
Short-term: The funds will go into sales in India, building regulatory, distribution and commercial teams for the US, Europe and Africa, and further product development.
Long-term: If Spandan wins US and EU approval, an Indian small-city start-up could become an exporter of low-cost heart diagnostics, and wider use in India could help detect heart problems earlier in rural areas.
Who is affected: Rural patients and frontline health workers, doctors offering remote consultations, medtech founders in tier 2 and tier 3 cities, and investors in Indian health hardware.
Key Takeaway
Dehradun-based Sunfox Technologies raised US$7 million on 7 October 2026 to take its smartphone-linked Spandan ECG device, already used in more than 20,000 Indian villages, to wider Indian and global markets.
Questions and Answers
What does Sunfox Technologies make?
It makes Spandan, a portable ECG device that records the heart's electrical activity using a smartphone, so readings can be taken outside hospitals and shared with doctors.
How much did Sunfox raise and who invested?
It raised US$7 million, about Rs 67 crore, in a Series A round led by Ashish Kacholia, Lashit Sanghvi, Alchemy Capital and 3one4 Capital, as reported on 7 October 2026.
Where is Spandan approved for use?
The company says it has regulatory approval in India, Ghana, Kenya, Tanzania and South Africa, and is pursuing approval in the US and the EU.
Why is this significant for small-city founders?
Sunfox was founded and is based in Dehradun, showing that a medical hardware start-up from a tier 2 city can scale nationally and attract major investors.
Sourced and fact-checked by the Peepals Global Editorial Team
Coal stock drawdown at power plants more than halves in October, says ministry
Drishyam 3 earns Rs 245.50 crore net in first week, beating Drishyam 2
Reported, fact-checked and published by the Peepals Global Editorial Team.
Advertisement
